CNMDCONMED Corporation
$44.43-11% 1Y
$44.43
$32.1152 weeks$51.88
CNMD in its own filings
CNMD's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
478
Events found in the filings · across 2,250 filings · the record starts in 1995
- Hard flags
- 1
Hard flags
- Most recent filing
- Jul 29, 2026
Most recent filing · Form 10-Q
- Record starts
- Mar 29, 1995
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 4, 2026
- Late periodic reporthistorical
- 2003-04-01
- Security removed from listing or deregistered2 occurrences · usually a matured note or preferred class, not the common shares
- 2020-05-26
- SEC comment-letter activity28 occurrences
- 2018-10-29
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jun 17, 2026On June 17, 2026, CONMED Corporation (the “Company”) announced that John E. Gallagher has been appointed to serve as the Company’s Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the “Effective Date”)Director or officer change · Form 8-K
- Jun 4, 2026On June 3, 2026, CONMED Corporation, a Delaware corporation (“CONMED”), entered into separate, privately negotiated purchase agreements (the “Purchase Agreements”) with certain holders of its 2.25% Convertible Senior Notes due 2027 (the “Notes”)Material agreement entered · Form 8-K
- Jun 1, 2026On May 27, 2026, CONMED Corporation, a Delaware corporation (“CONMED”) entered into the First Omnibus Amendment and Increased Facility Activation Notice (the “First Amendment”), among CONMED and its subsidiary Linvatec Nederland B.V., a Netherlands private limited company ( besloten vennootschap ), as borrowers …Material agreement entered · Form 8-K
- May 20, 2026Appointment of Non-Employee Directors On May 19, 2026, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.Director or officer change · Form 8-K
- Mar 13, 2026On March 13, 2026, CONMED Corporation (the “Company”) announced that Andrew Moller, age 51, will be appointed Interim Principal Financial Officer of the Company effective March 15, 2026.Director or officer change · Form 8-K
- Jan 12, 2026J.P. Morgan 44 th Annual Healthcare Conference Pat J. Beyer President and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer January 12 th, 2026.Regulation FD disclosure · press release
- Jan 8, 2026On January 8, 2026, CONMED Corporation (the “Company”) announced the separation of Mr. Todd Garner, the Company’s Chief Financial Officer (“CFO”), effective on the earlier of March 15, 2026 or the date on which the Company appoints a new permanent CFO (the “CFO Transition Date”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…